0 Comentários
0 Compartilhamentos
793 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
-
Global CAR-T Cell Therapy Market Growth at 17.5% CAGR Through 2030Increasing research and development activities in cell-based therapies are supporting the expansion of the CAR-T cell therapy market. Pharmaceutical and biotechnology companies are investing heavily in clinical trials and advanced technologies. These efforts are accelerating the development of new and effective cancer treatments. CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030...0 Comentários 0 Compartilhamentos 6K Visualizações 0 Anterior
-
Global Cervical Cancer Therapeutics Market Future Growth ProspectsThe global cervical cancer therapeutics market size was valued at USD 6.33 billion in 2024 and is expected to grow from USD 6.61 billion in 2025 to reach USD 9.38 billion in 2033, growing at a CAGR of 4.47% during the forecast period (2025–2033). Key Highlights North America dominated the global cervical cancer therapeutics market and is expected to maintain its leading...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Global Interventional Oncology Market Trends and Growth ForecastA speciality area of medicine called interventional oncology focuses on using minimally invasive, image-guided techniques to diagnose and treat cancer. It encompasses techniques such as tumor ablation, embolization, and targeted drug delivery, which allow physicians to treat cancerous tissues accurately while minimizing harm to surrounding healthy areas. These approaches offer significant...0 Comentários 0 Compartilhamentos 5K Visualizações 0 Anterior
-
Global Raloxifene Hydrochloride Market Growing at 5.8% CAGR Driven by Dual Benefits in Bone Health & Cancer PreventionAccording to a new report from Intel Market Research, the global Raloxifene Hydrochloride market was valued at USD 1.05 billion in 2025 and is projected to reach USD 1.75 billion by 2034, growing at a steady CAGR of 5.8% during the forecast period (2026-2034). This growth is fueled by increasing osteoporosis prevalence among aging populations, expanding applications in breast cancer prevention,...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
-
Immunotherapy Impact on the Anti-cancer Drugs MarketThe rapid growth of the biotechnology sector is supporting breakthroughs in anti-cancer drug development. Researchers are leveraging advanced technologies such as gene therapy and cell-based therapies. These innovations are opening new possibilities in cancer treatment. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and...0 Comentários 0 Compartilhamentos 5K Visualizações 0 Anterior
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
© 2026 Myliveroom — Live Events & Online Communities
Portuguese